Skip directly to site content Skip directly to search
Español | Other Languages
U.S. flag An official website of the United States government
Official icon

Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Lock icon

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People CDC Logo CDC Logo
Vaccine Safety

Vaccine Safety Monitoring

Print
Minus
Related Pages

nurse filling up a syringe

CDC monitors the safety of vaccines by:

  • Performing high-quality vaccine safety research.
  • Making determinations about whether vaccines caused reactions in certain cases and helping to learn about preventable risk factors.
  • Identifying vaccine adverse events through public health surveillance.

CDC’s Immunization Safety Office conducts four primary vaccine safety activities:

Vaccine Adverse Event Reporting System (VAERS)

An early warning system that helps CDC and FDA monitor problems following vaccination.  Anyone can report suspected vaccine reactions and issues to VAERS.

Clinical Immunization Safety Assessment (CISA) Project

A partnership between CDC and several medical centers that conduct clinical research on vaccine-associated health risks in certain groups of people.

Vaccine Safety Datalink (VSD)

A collaboration between CDC and several health care organizations that allows ongoing monitoring and proactive searches of vaccine-related data.

Emergency Preparedness for Vaccine Safety

In the event of a disease outbreak in which a mass vaccination campaign is needed, CDC activates emergency preparedness activities to ensure that vaccines remain safe.

Related Links
  • How Vaccines are Tested, Licensed, and Monitored for Safety
  • Reporting Adverse Events
  • Understanding Side Effects and Adverse Events
  • Vaccine Safety Research
Top of Page
Last Reviewed: August 28, 2020
Source: Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP)
  • Facebook
  • Twitter
  • LinkedIn
  • Syndicate
homeVaccine Safety
  • Safety Information by Vaccineplus icon
    • Chickenpox (Varicella) Vaccines
    • COVID-19 Vaccines
    • Diphtheria, Tetanus, and Pertussis Vaccines
    • Haemophilus influenzae type b (Hib) Vaccines
    • Hepatitis A Vaccines
    • Hepatitis B Vaccines
    • Human Papillomavirus (HPV) Vaccineplus icon
      • Questions about HPV Vaccine Safety
    • Influenza (Flu) Vaccines
    • Measles, Mumps, Rubella (MMR) Vaccinesplus icon
      • MMR Safety Studies
    • Measles, Mumps, Rubella, Varicella (MMRV) Vaccinesplus icon
      • VSD MMRV Safety Study
      • MMRV Safety Studies
      • MMRV and Febrile Seizures
    • Meningococcal Vaccines
    • Mpox Vaccines
    • Pneumococcal Vaccines
    • Polio Vaccine
    • Respiratory Syncytial Virus (RSV) Vaccine
    • Rotavirus Vaccine
    • Shingles (Herpes Zoster) Vaccines
    • Smallpox Vaccines
  • Questions and Concernsplus icon
    • Adjuvants
    • Autismplus icon
      • CDC Statement: 2004 Pediatrics Paper on MMR and Autism
    • Fainting after Vaccination
    • Febrile Seizures
    • Guillain-Barre Syndrome
    • Multiple Vaccinations at Once
    • Sudden Infant Death Syndrome (SIDS)
    • Thimerosalplus icon
      • CDC Study (2010 ) on Thimerosal and Risk of Autism
      • Thimerosal FAQs
      • Related Scientific Articles
      • Infant and Environmental Exposures to Thimerosal 2007 Study
      • Timeline: Thimerosal in Vaccines
    • Vaccines During Pregnancy FAQs
    • FAQs about Vaccine Recalls
    • Historical Vaccine Safety Concernsplus icon
      • GBS and Menactra Vaccine FAQs
      • Gardasil Vaccine Recall (2013) FAQs
      • Hep B and Multiple Sclerosis FAQs
      • Hib Vaccine Recall (2007) Summary
      • Narcolepsy Following Pandemrix Influenza Vaccination in Europe
  • Information for Healthcare Providersplus icon
    • Talking to Patients About Vaccine Safety
    • Reporting Adverse Events
    • Resources for Healthcare Providers
  • Information for Parents and Caregiversplus icon
    • Vaccine Safety FAQs
  • Researchplus icon
    • Publications
    • Partner Reports on Vaccine Safety
    • ISO Scientific Agenda
  • Ensuring Safetyplus icon
    • Overview, History, and How It Works
    • Side Effects and Adverse Events
    • Vaccine Safety Monitoringplus icon
      • Vaccine Adverse Event Reporting System (VAERS)
      • CISAplus icon
        • CISA Resources for Healthcare Professionals
        • Evaluation
        • Clinical Research Studies
        • Historical Background 2001-12
        • Publications
        • Technical Reports
      • Vaccine Safety Datalink (VSD)plus icon
        • Accessing Data from Vaccine Safety Datalink
        • Data Sharing Guidelines
        • Vaccine Safety Datalink Publications
      • V-safe
      • V-safe Publications
      • Emergency Preparedness
    • Vaccine Safety Partners
  • About ISO
email_03Get Email Updates

To receive email updates about this page, enter your email address:

What's this?
  • About CDC
  • Contact Us
  • 800-232-4636
Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
  • Contact Us
    Call 800-232-4636
    Email Us
    • About CDC
    • Jobs
    • Funding
    • Accessibility
    • External Links
    • Privacy
    • Policies
    • No Fear Act
    • FOIA
    • OIG
    • Nondiscrimination
    • Vulnerability Disclosure Policy
    • Facebook
    • Twitter
    • Instagram
    • LinkedIn
    • Youtube
    • Pinterest
    • Snapchat
    • Email
    • Español
    • 繁體中文
    • Tiếng Việt
    • 한국어
    • Tagalog
    • Русский
    • العربية
    • Kreyòl Ayisyen
    • Français
    • Polski
    • Português
    • Italiano
    • Deutsch
    • 日本語
    • فارسی
    • English
  • U.S. Department of Health & Human Services
  • Accessibility
  • External Links
  • Privacy
  • Policies
  • No Fear Act
  • FOIA
  • Nondiscrimination
  • OIG
  • Vulnerability Disclosure Policy
  • USA.gov
SAS stats